133 related articles for article (PubMed ID: 21437657)
1. Endogenous expression of Neuregulin-1 (Nrg1) as a potential modulator of prolactin (PRL) secretion in GH3 cells.
Zhao W; Shen Y; Ren S
Cell Tissue Res; 2011 May; 344(2):313-20. PubMed ID: 21437657
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin-1 (Nrg1) is mainly expressed in rat pituitary gonadotroph cells and possibly regulates prolactin (PRL) secretion in a juxtacrine manner.
Zhao W; Ren SG
J Neuroendocrinol; 2011 Dec; 23(12):1252-62. PubMed ID: 21919974
[TBL] [Abstract][Full Text] [Related]
3. Activities of bone morphogenetic proteins in prolactin regulation by somatostatin analogs in rat pituitary GH3 cells.
Tsukamoto N; Otsuka F; Miyoshi T; Inagaki K; Nakamura E; Suzuki J; Ogura T; Iwasaki Y; Makino H
Mol Cell Endocrinol; 2011 Jan; 332(1-2):163-9. PubMed ID: 20970474
[TBL] [Abstract][Full Text] [Related]
4. Follistatin, induced by thyrotropin-releasing hormone (TRH), plays no role in prolactin expression but affects gonadotropin FSHbeta expression as a paracrine factor in pituitary somatolactotroph GH3 cells.
Oride A; Kanasaki H; Purwana IN; Mutiara S; Miyazaki K
Regul Pept; 2009 Aug; 156(1-3):65-71. PubMed ID: 19446581
[TBL] [Abstract][Full Text] [Related]
5. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
Frohnert PW; Stonecypher MS; Carroll SL
Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
[TBL] [Abstract][Full Text] [Related]
7. HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy.
Fukuoka H; Cooper O; Mizutani J; Tong Y; Ren SG; Bannykh S; Melmed S
Mol Endocrinol; 2011 Jan; 25(1):92-103. PubMed ID: 21106881
[TBL] [Abstract][Full Text] [Related]
8. Melanocortin peptides stimulate prolactin gene expression and prolactin accumulation in rat pituitary aggregate cell cultures.
Langouche L; Hersmus N; Papageorgiou A; Vankelecom H; Denef C
J Neuroendocrinol; 2004 Aug; 16(8):695-703. PubMed ID: 15271062
[TBL] [Abstract][Full Text] [Related]
9. [Endogenous neuregulin-1 expression in the anterior pituitary of female Wistar-Furth rats during the estrous cycle].
Zhao WJ; Ren SG
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):921-7. PubMed ID: 21690038
[TBL] [Abstract][Full Text] [Related]
10. Prolactin-releasing peptide receptor expressed in the pituitary in Mozambique tilapia Oreochromis mossambicus: an aspect of prolactin regulatory mechanisms.
Watanabe S; Kaneko T
Gen Comp Endocrinol; 2010 May; 167(1):27-34. PubMed ID: 20226787
[TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptors and epidermal growth factor, amphiregulin and neuregulin in bovine uteroplacental tissues during gestation.
Akbalik ME; Ketani MA
Placenta; 2013 Dec; 34(12):1232-42. PubMed ID: 24138732
[TBL] [Abstract][Full Text] [Related]
12. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors.
Schmitt M; Walker MP; Richards RG; Bocchinfuso WP; Fukuda T; Medina D; Kittrell FS; Korach KS; DiAugustine RP
Mol Carcinog; 2006 Jul; 45(7):490-505. PubMed ID: 16482517
[TBL] [Abstract][Full Text] [Related]
13. Suppression of prolactin expression by cabergoline requires prolactin regulatory element-binding protein (PREB) in GH3 cells.
Zhang W; Murao K; Imachi H; Iwama H; Chen K; Fei Z; Zhang X; Ishida T; Tamiya T
Horm Metab Res; 2010 Jul; 42(8):557-61. PubMed ID: 20411477
[TBL] [Abstract][Full Text] [Related]
14. Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells.
Song JY; Jin L; Lloyd RV
Cancer Res; 1989 Mar; 49(5):1247-53. PubMed ID: 2917354
[TBL] [Abstract][Full Text] [Related]
15. Heregulin regulates prolactinoma gene expression.
Vlotides G; Cooper O; Chen YH; Ren SG; Greenman Y; Melmed S
Cancer Res; 2009 May; 69(10):4209-16. PubMed ID: 19401448
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.
Kansra S; Yamagata S; Sneade L; Foster L; Ben-Jonathan N
Mol Cell Endocrinol; 2005 Jul; 239(1-2):27-36. PubMed ID: 15950373
[TBL] [Abstract][Full Text] [Related]
17. Induction of classical lactotropes by epidermal growth factor in rat pituitary cell cultures.
Felix R; Meza U; Cota G
Endocrinology; 1995 Mar; 136(3):939-46. PubMed ID: 7867603
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting MAPK14 showed anti-prolactinoma effect.
Ding QY; Zhang Y; Ma L; Chen YG; Wu JH; Zhang HF; Wang X
BMC Endocr Disord; 2020 Sep; 20(1):138. PubMed ID: 32894113
[TBL] [Abstract][Full Text] [Related]
19. Pectic acid effects on prolactin secretion in GH3/B6 rat pituitary cell line.
Eslimi D; Sepehri H; Rassouli Y; Khoei S; Goliaei B
Iran Biomed J; 2008 Jul; 12(3):167-72. PubMed ID: 18762820
[TBL] [Abstract][Full Text] [Related]
20. Neuregulin 4 (Nrg4) cooperates with melatonin to regulate the PRL expression via ErbB4/Erk signaling pathway as a potential prolactin (PRL) regulator.
Lin WW; Ou GY; Dai HF; Zhao WJ
J Cell Biochem; 2024 May; 125(5):e30551. PubMed ID: 38465779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
